Skip to main content
Item(s) Added to Cart

0 item(s) Subtotal $0,00

Emerging Endoscopic Bariatric and Metabolic Therapies and the Essential Role of the RDN

Emerging Endoscopic Bariatric and Metabolic Therapies and the Essential Role of the RDN
FNCE 2025 Buy 2 Get 1 Free
Read Details

Buy 2 get 1 free on FNCE® 2025 session recordings only; FNCE® 2025 collections are excluded. Discount will be auto-applied – no code needed.

Emerging Endoscopic Bariatric and Metabolic Therapies and the Essential Role of the RDN

Your Price $10.00 - $54.00

This session will familiarize RDNs with emerging endoscopic bariatric therapies for obesity and emphasize their role in the interdisciplinary care team. Advancements in procedures such as endoscopic sleeve gastroplasty (ESG), transoral outlet reduction (TORe), vertical sleeve gastrectomy revisions and intragastric balloons have expanded treatment options and improved patient outcomes.

Participants will learn how RDNs contribute to patient success through pre-and post procedure nutrition care, behavior change counseling, and long-term weight management strategies. The session will also cover emerging research and future treatment options currently under investigation, offering insight into how these therapies may evolve and influence clinical practice.

RDNs will leave with a deeper understanding of their role in optimizing outcomes alongside physicians, nurse practitioners, and behavioral health professionals in a collaborative care model. This session will empower dietitians to advocate for their experience and take an active role in advancing patient-centered, comprehensive obesity treatment.

Product Publish Details

Release Date: October 15, 2025

SKU: FNCE25155

CPEU: 1.00 (Valid Until September 16, 2028)

Learning Objectives

  • Define and describe endoscopic bariatric therapies, their mechanism of action and expected outcomes in order to offer treatment options to their patients and clients.
  • Describe recent developments and research in the area of endoscopic bariatric therapies and how they could influence the future use of these treatments.
  • Explain the need for RDNs and describe their role in the treatment of obesity utilizing endoscopic bariatric therapies to produce optimal health outcomes.

Performance Indicators

  • 5.1.5 Demonstrates effective, appropriate and timely consultation with experts and others.
  • 8.1.1 Advocates for and adheres to workplace safety legislation, regulations and organizational policies.
  • 11.3.3 Prioritizes specific nutrition problems to inform nutrition care plans and processes.

Placeholder Headshot

Lacie Peterson, PhD, RDN, BC-ADM, CDCES, FADCES, FAND

Moderator

Placeholder Headshot

Laura Sebring, MS, RD, CSOWM, LDN

Speaker

Check Out Our Current Sales

From seasonal specials celebrating commemorative events and awareness campaigns to sales on soon-to-expire CPE activities and book titles for which new editions are just around the corner, don't miss this opportunity to grab cutting-edge resources at discounted prices.